Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Abraxane paclitaxel regulatory update

EMEA's CHMP recommended approval of ABBI's Abraxane paclitaxel to treat metastatic breast cancer

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE